406 related articles for article (PubMed ID: 32789702)
21. Metabolomics of papillary thyroid carcinoma tissues: potential biomarkers for diagnosis and promising targets for therapy.
Shang X; Zhong X; Tian X
Tumour Biol; 2016 Aug; 37(8):11163-75. PubMed ID: 26935059
[TBL] [Abstract][Full Text] [Related]
22. Identification of differential metabolic characteristics between tumor and normal tissue from colorectal cancer patients by gas chromatography-mass spectrometry.
Ning W; Li H; Meng F; Cheng J; Song X; Zhang G; Wang W; Wu S; Fang J; Ma K; Yang J; Pei D; Dong F
Biomed Chromatogr; 2017 Nov; 31(11):. PubMed ID: 28475217
[TBL] [Abstract][Full Text] [Related]
23. Metabotyping of human colorectal cancer using two-dimensional gas chromatography mass spectrometry.
Mal M; Koh PK; Cheah PY; Chan EC
Anal Bioanal Chem; 2012 Apr; 403(2):483-93. PubMed ID: 22374317
[TBL] [Abstract][Full Text] [Related]
24. Multiplex screening of 275 plasma protein biomarkers to identify a signature for early detection of colorectal cancer.
Bhardwaj M; Weigl K; Tikk K; Benner A; Schrotz-King P; Brenner H
Mol Oncol; 2020 Jan; 14(1):8-21. PubMed ID: 31652396
[TBL] [Abstract][Full Text] [Related]
25. Ultra‑performance liquid chromatography coupled with quadrupole time‑of‑flight mass spectrometry‑based metabolic profiling of human serum prior to and following radical resection of colorectal carcinoma.
Chen L; Zhang C; Gui Q; Chen Y; Yang Y
Mol Med Rep; 2015 Nov; 12(5):6879-86. PubMed ID: 26352758
[TBL] [Abstract][Full Text] [Related]
26. [Integrated analysis of serum untargeted metabolomics and targeted bile acid metabolomics for identification of diagnostic biomarkers for colorectal cancer].
Wang X; Zhu Y; Zhou H; Huang Z; Chen H; Zhang J; Yang S; Chen G; Zhang Q
Nan Fang Yi Ke Da Xue Xue Bao; 2023 Mar; 43(3):443-453. PubMed ID: 37087590
[TBL] [Abstract][Full Text] [Related]
27. Metabolic profiling analysis for clinical urine of colorectal cancer.
Ning W; Qiao N; Zhang X; Pei D; Wang W
Asia Pac J Clin Oncol; 2021 Aug; 17(4):403-413. PubMed ID: 34164923
[TBL] [Abstract][Full Text] [Related]
28. Metabonomics identifies serum metabolite markers of colorectal cancer.
Tan B; Qiu Y; Zou X; Chen T; Xie G; Cheng Y; Dong T; Zhao L; Feng B; Hu X; Xu LX; Zhao A; Zhang M; Cai G; Cai S; Zhou Z; Zheng M; Zhang Y; Jia W
J Proteome Res; 2013 Jun; 12(6):3000-9. PubMed ID: 23675754
[TBL] [Abstract][Full Text] [Related]
29. Multiplex quantitation of 270 plasma protein markers to identify a signature for early detection of colorectal cancer.
Bhardwaj M; Weigl K; Tikk K; Holland-Letz T; Schrotz-King P; Borchers CH; Brenner H
Eur J Cancer; 2020 Mar; 127():30-40. PubMed ID: 31972396
[TBL] [Abstract][Full Text] [Related]
30. Exploratory metabolomic study to identify blood-based biomarkers as a potential screen for colorectal cancer.
Asante I; Pei H; Zhou E; Liu S; Chui D; Yoo E; Conti DV; Louie SG
Mol Omics; 2019 Feb; 15(1):21-29. PubMed ID: 30515501
[TBL] [Abstract][Full Text] [Related]
31. Serum immunoinflammation-related protein complexes discriminate between inflammatory bowel disease and colorectal cancer.
Sun YH; Li J; Shu HJ; Li ZL; Qian JM
Clin Transl Oncol; 2019 Dec; 21(12):1680-1686. PubMed ID: 30955196
[TBL] [Abstract][Full Text] [Related]
32. Salivary metabolomics with machine learning for colorectal cancer detection.
Kuwabara H; Katsumata K; Iwabuchi A; Udo R; Tago T; Kasahara K; Mazaki J; Enomoto M; Ishizaki T; Soya R; Kaneko M; Ota S; Enomoto A; Soga T; Tomita M; Sunamura M; Tsuchida A; Sugimoto M; Nagakawa Y
Cancer Sci; 2022 Sep; 113(9):3234-3243. PubMed ID: 35754317
[TBL] [Abstract][Full Text] [Related]
33. Global gas chromatography/time-of-flight mass spectrometry (GC/TOFMS)-based metabonomic profiling of lyophilized human feces.
Phua LC; Koh PK; Cheah PY; Ho HK; Chan EC
J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Oct; 937():103-13. PubMed ID: 24029555
[TBL] [Abstract][Full Text] [Related]
34. A rapid GC method coupled with quadrupole or time of flight mass spectrometry for metabolomics analysis.
Wang Y; Zhou L; Zhou Y; Zhao C; Lu X; Xu G
J Chromatogr B Analyt Technol Biomed Life Sci; 2020 Dec; 1160():122355. PubMed ID: 32920480
[TBL] [Abstract][Full Text] [Related]
35. Noninvasive Detection of Colorectal Carcinomas Using Serum Protein Biomarkers.
Ivancic MM; Megna BW; Sverchkov Y; Craven M; Reichelderfer M; Pickhardt PJ; Sussman MR; Kennedy GD
J Surg Res; 2020 Feb; 246():160-169. PubMed ID: 31586890
[TBL] [Abstract][Full Text] [Related]
36. Non-invasive fecal metabonomic detection of colorectal cancer.
Phua LC; Chue XP; Koh PK; Cheah PY; Ho HK; Chan EC
Cancer Biol Ther; 2014 Apr; 15(4):389-97. PubMed ID: 24424155
[TBL] [Abstract][Full Text] [Related]
37. A blood-based biomarker panel for stratifying current risk for colorectal cancer.
Marshall KW; Mohr S; Khettabi FE; Nossova N; Chao S; Bao W; Ma J; Li XJ; Liew CC
Int J Cancer; 2010 Mar; 126(5):1177-86. PubMed ID: 19795455
[TBL] [Abstract][Full Text] [Related]
38. Serum CCL20 combined with IL-17A as early diagnostic and prognostic biomarkers for human colorectal cancer.
Wang D; Yuan W; Wang Y; Wu Q; Yang L; Li F; Chen X; Zhang Z; Yu W; Maimela NR; Cao L; Wang D; Wang J; Sun Z; Liu J; Zhang Y
J Transl Med; 2019 Aug; 17(1):253. PubMed ID: 31387598
[TBL] [Abstract][Full Text] [Related]
39. Novel serum nucleosomics biomarkers for the detection of colorectal cancer.
Holdenrieder S; Dharuman Y; Standop J; Trimpop N; Herzog M; Hettwer K; Simon K; Uhlig S; Micallef J
Anticancer Res; 2014 May; 34(5):2357-62. PubMed ID: 24778043
[TBL] [Abstract][Full Text] [Related]
40. An integrated proteomics and metabolomics approach for defining oncofetal biomarkers in the colorectal cancer.
Ma Y; Zhang P; Wang F; Liu W; Yang J; Qin H
Ann Surg; 2012 Apr; 255(4):720-30. PubMed ID: 22395091
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
